Effect of plerixafor in multiple myeloma patients for stem cell mobilisation

Trial Profile

Effect of plerixafor in multiple myeloma patients for stem cell mobilisation

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2015

At a glance

  • Drugs Plerixafor (Primary) ; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Granulocyte colony-stimulating factors; Lenalidomide
  • Indications Stem cell mobilisation
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top